E-ISSN 2231-3206 | ISSN 2320-4672
 
2024, Vol: 14, Issue: 9
14 / 9Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles
Required files to be uploaded

Authorship Declaration

Original Research
Online Published: 27 Oct 2021
 


A comparative study evaluating the efficacy and safety of once daily versus three times daily mesalazine in ulcerative colitis

Hiba Salam, Bhagyalekshmi Narayanapillai, Ramesh Mohan.


Abstract
Background: Ulcerative Colitis (UC) is an inflammatory disease affecting the colonic mucosa. Oral Mesalazine is one of the established treatments for UC and the conventional dosing regimen is 3 times a day. However, medical management favors lesser dosing frequency and the evidence of once daily dosing efficacy is not established by randomized controlled trials.

Aim and Objective: Aim and objective of the study was to assess the efficacy and safety of once daily versus 3 times daily Mesalazine in UC.

Materials and Methods: This prospective study was carried out in a sample of patients newly diagnosed with mild to moderately active UC. Patients were grouped into to once daily and 3 times daily groups. Outcomes were measured by Partial Mayo score, Individual Symptom Assessment, endoscopy and Histological score at the end of 8th week. Primary endpoint was proportion of patients achieving clinical remission and response with Partial Mayo score at the end of 8th week from start of treatment. Analysis was done using Epi Info Version 7.

Results: Sixty patients were assessed (31 patients in OD group and 29 patients in TID group). 61.3% patients in OD group and 62.1% in TID group achieved remission, whereas 71% in the OD group and 58.6% in the TID group achieved clinical response to treatment at the end of 8th week with Partial Mayo score.

Conclusion: The study concludes that once daily dosing regimen of Mesalazine is as efficacious and safe as 3 times daily dosing regimen in inducing remission in mild to moderate UC.

Key words: Oral Mesalazine; Ulcerative Colitis; Once Daily Dose; Three Times Daily Dose


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Hiba Salam
Articles by Bhagyalekshmi Narayanapillai
Articles by Ramesh Mohan
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Salam H, Narayanapillai B, Mohan R. A comparative study evaluating the efficacy and safety of once daily versus three times daily mesalazine in ulcerative colitis. Natl J Physiol Pharm Pharmacol. 2021; 11(12): 1394-1398. doi:10.5455/njppp.2021.11.10363202116102021

Web Style

Salam H, Narayanapillai B, Mohan R. A comparative study evaluating the efficacy and safety of once daily versus three times daily mesalazine in ulcerative colitis. https://www.njppp.com/?mno=130349 [Access: September 12, 2024]. doi:10.5455/njppp.2021.11.10363202116102021

AMA (American Medical Association) Style

Salam H, Narayanapillai B, Mohan R. A comparative study evaluating the efficacy and safety of once daily versus three times daily mesalazine in ulcerative colitis. Natl J Physiol Pharm Pharmacol. 2021; 11(12): 1394-1398. doi:10.5455/njppp.2021.11.10363202116102021


Vancouver/ICMJE Style

Salam H, Narayanapillai B, Mohan R. A comparative study evaluating the efficacy and safety of once daily versus three times daily mesalazine in ulcerative colitis. Natl J Physiol Pharm Pharmacol. (2021), [cited September 12, 2024]; 11(12): 1394-1398. doi:10.5455/njppp.2021.11.10363202116102021


Harvard Style

Salam, H., Narayanapillai, . B. & Mohan, . R. (2021) A comparative study evaluating the efficacy and safety of once daily versus three times daily mesalazine in ulcerative colitis. Natl J Physiol Pharm Pharmacol, 11 (12), 1394-1398. doi:10.5455/njppp.2021.11.10363202116102021


Turabian Style

Salam, Hiba, Bhagyalekshmi Narayanapillai, and Ramesh Mohan. 2021. A comparative study evaluating the efficacy and safety of once daily versus three times daily mesalazine in ulcerative colitis. National Journal of Physiology, Pharmacy and Pharmacology, 11 (12), 1394-1398. doi:10.5455/njppp.2021.11.10363202116102021


Chicago Style

Salam, Hiba, Bhagyalekshmi Narayanapillai, and Ramesh Mohan. "A comparative study evaluating the efficacy and safety of once daily versus three times daily mesalazine in ulcerative colitis." National Journal of Physiology, Pharmacy and Pharmacology 11 (2021), 1394-1398. doi:10.5455/njppp.2021.11.10363202116102021


MLA (The Modern Language Association) Style

Salam, Hiba, Bhagyalekshmi Narayanapillai, and Ramesh Mohan. "A comparative study evaluating the efficacy and safety of once daily versus three times daily mesalazine in ulcerative colitis." National Journal of Physiology, Pharmacy and Pharmacology 11.12 (2021), 1394-1398. Print. doi:10.5455/njppp.2021.11.10363202116102021


APA (American Psychological Association) Style

Salam, H., Narayanapillai, . B. & Mohan, . R. (2021) A comparative study evaluating the efficacy and safety of once daily versus three times daily mesalazine in ulcerative colitis. National Journal of Physiology, Pharmacy and Pharmacology, 11 (12), 1394-1398. doi:10.5455/njppp.2021.11.10363202116102021




Most Viewed Articles
Most Accessed Articles

  • Applications of computer science in Pharmacy: An overview
    Shivraj Popat Jadhav, Komal Nikam, Anand Gandhi, Kishor Salunkhe, Narendra Shinde.
    Natl J Physiol Pharm Pharmacol. 2012; 2(1): 1-9
    » Abstract

  • How to calculate sample size in animal studies?
    Hitesh Shah
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 35-39
    » Abstract

  • Chlorhexidine:The gold standard in chemical plaque control [English]
    Setu mathur, Tanu mathur,Rahul shrivastava, Rohit khatri
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 45-50
    » Abstract

  • Assessment of Nutritional Status of Pregnant Women Attending the City Tebessa PMI (Algeria) [English]
    Taleb Salima, Kaibi Mounira, Deghboudj Nadjia
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 97-105
    » Abstract

  • Difference in pulmonary function test among the athletic and sedentary population
    ShobhaRani Vedala, Niranjan Paul, Abhay B Mane
    Natl J Physiol Pharm Pharmacol. 2013; 3(2): 118-123
    » Abstract » doi: 10.5455/njppp.2013.3.109-114

    •
    Most Downloaded
    Top Downloaded Articles

  • How to calculate sample size in animal studies?
    Hitesh Shah
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 35-39
    » Abstract

  • Applications of computer science in Pharmacy: An overview
    Shivraj Popat Jadhav, Komal Nikam, Anand Gandhi, Kishor Salunkhe, Narendra Shinde.
    Natl J Physiol Pharm Pharmacol. 2012; 2(1): 1-9
    » Abstract

  • Evaluation of potential drug-drug interaction in indoor patients of pediatric department of tertiary care hospital
    Simran Patel, Mayur Chaudhari, Nrupal Patel
    Natl J Physiol Pharm Pharmacol. 2019; 9(10): 1012-1016
    » Abstract » doi: 10.5455/njppp.2019.9.0725209072019

  • Chlorhexidine:The gold standard in chemical plaque control [English]
    Setu mathur, Tanu mathur,Rahul shrivastava, Rohit khatri
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 45-50
    » Abstract

  • Analyzing Pharmaceutical Industry [English]
    Veselin Tima Dickov, Dragan Mitrovic, Boris Milan Kuzman
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 1-8
    » Abstract » doi: 10.5455/njppp.2011.1.1-8

    •
    Most Cited Articles
    Most Cited Articles

    About National Journal of Physiology, Pharmacy and Pharmacology

      National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal.  The journal is having open access polic ... Read more.



    For best results, please use Internet Explorer or Google Chrome.

    Contact Information

    Publisher

    publishernjppp@gmail.com

     

    Editorial query

    editornjppp1@gmail.com

    MOB - 8780040272

     

     

     
    POLICIES & JOURNAL LINKS
    Author Login
    Reviewer Login
    About Publisher
    Advertising Policy
    Author's Rights and Obligations
    Conflict of Interest Policy
    Copyright Information
    Digital Archiving & Preservation Policies
    Editorial Policies
    Peer Review Policy
    Editorial & Peer Review Process
    License Information
    Open Access Policy
    Plagiarism Policy
    Privacy Policy
    Protection of Research Participants (Statement On Human And Animal Rights)
    Publication Ethics and Publication Malpractice Statement
    Corrections, Retractions & Expressions of Concern
    Self-Archiving Policies
    Statement of Informed Consent
    Terms of Use